Abstract | AIM: To determine plasma B-type natriuretic peptide (BNP) levels in children with heart diseases before medical or surgical treatment for monitoring therapeutic efficacy in an observational prospective clinical trial at tertiary care centre. METHODS: RESULTS: Most types of heart disease are associated with increased mean plasma BNP levels before treatment, with highest values in children with CMP (BNP 6165 pg/mL in dilated CMP vs. 817 pg/mL in hypertrophic, vs. 1236 pg/mL in restrictive CMP, each p < 0.05). Children with PAH showed a significant decrease in BNP levels under medical treatment (mean BNP 981 pg/mL before vs. 26 pg/mL under treatment, p < 0.05). Children with univentricular CHD undergoing surgical staged palliation showed a significant decrease in BNP levels after bidirectional cavopulmonary anastomosis (BDCP) (BNP 109 pg/mL before vs. 70 pg/mL after BDCP, p < 0.05). CONCLUSION: Plasma BNP levels are elevated in children with heart disease before treatment and are a useful laboratory parameter under treatment during long-term follow-up.
|
Authors | Walter Knirsch, Eliane Häusermann, Margrit Fasnacht, Martin Hersberger, Peter Gessler, Urs Bauersfeld |
Journal | Acta paediatrica (Oslo, Norway : 1992)
(Acta Paediatr)
Vol. 100
Issue 9
Pg. 1213-6
(Sep 2011)
ISSN: 1651-2227 [Electronic] Norway |
PMID | 21388448
(Publication Type: Journal Article)
|
Copyright | © 2011 The Author(s)/Acta Paediatrica © 2011 Foundation Acta Paediatrica. |
Chemical References |
- Natriuretic Peptide, Brain
|
Topics |
- Adolescent
- Cardiomyopathies
(blood)
- Child
- Child, Preschool
- Female
- Heart Defects, Congenital
(blood)
- Heart Ventricles
- Hemodynamics
- Humans
- Hypertension, Pulmonary
(blood)
- Infant
- Infant, Newborn
- Male
- Natriuretic Peptide, Brain
(blood)
- Prospective Studies
- Statistics as Topic
- Statistics, Nonparametric
|